SF2645 — Formulary Committee members with a potential conflict of interest participation in committee communications and discussions authorization provision, public comment process for recommendations to the Formulary Committee development by the commissioner of human services requirement provision, and Minnesota Rare Disease Advisory Council expertise sought by the Formulary Committee requirement provision

SF2645 — Formulary Committee members with a potential conflict of interest participation in committee communications and discussions authorization provision, public comment process for recommendations to the Formulary Committee development by the commissioner of human services requirement provision, and Minnesota Rare Disease Advisory Council expertise sought by the Formulary Committee requirement provision · Informed CitizenryThis bill amends Minnesota Statutes regarding the Formulary Committee, which advises the commissioner of human services on prescription drug lists and prior authorization requirements. Key changes…Open in Informed Citizenry